Medios HI detects both glaucoma and diabetic retinopathy from the same retinal image offline in under 10 seconds, reinforcing Remidio’s position as India’s ... Oct 22
With these approvals, Remidio continues to lead in the development of AI-driven ophthalmic diagnostics, aiming to bridge the gap in eye care delivery and ... May 02
Remidio Innovative Solutions, a global leader in AI-powered ophthalmic diagnostics, has announced a strategic partnership with RetinaRisk, a leading health tech company from Iceland, ... Apr 15
Primary-care based Diabetic Retinopathy (DR) screening can enable early detection, avoiding blindness due to DR for close to 425 million people living with diabetes ... Oct 10
The MEDIOS-AI, designed by Bangalore-based Remidio Innovative Solutions, will implement sensitive and scalable screening models for Diabetic Retinopathy.... Sep 27
Diabetic Retinopathy (DR), is asymptomatic and affects nearly 20% of the 70 million diabetic patients in India. ... Sep 11
-Advertisements-